We would like to inform our customers and partners that we are making every effort to ensure the continuity of our services during this time. We applied contingency plans to our production facilities, and — to date — our production is running under strict safety measures to protect the health of our staff. We will keep our customers informed as the situation evolves.
The biopharma and culture media industries have always been large users of different nutrients and growth factors from different origins, including animal-derived ingredients. In recent years, this industry is moving away from animal-based molecules and is looking for nutrients which are sustainable, allergen free, animal free and moreover reliably lot-to-lot consistent.
Given these requirements we have developed FN 110, a filtered yeast extract offering superior performance and high filtrability. FNI 110 is suitable in a broad range of applications such as cell culture, ready-to-use media and other biopharma markets.